GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » Other Financing

Almirall (Almirall) Other Financing : $202.5 Mil (TTM As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Almirall Other Financing?

Almirall's Other Financing for the three months ended in Jun. 2023 was $206.8 Mil.

Almirall's Other Financing for the trailing twelve months (TTM) ended in Jun. 2023 was $202.5 Mil.

Almirall Other Financing Historical Data

The historical data trend for Almirall's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Other Financing Chart

Almirall Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.98 -15.91 -6.64 -16.47 -11.14

Almirall Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.79 - -4.28 206.81 -

Almirall Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $202.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall Other Financing Related Terms

Thank you for viewing the detailed overview of Almirall's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (Almirall) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » Other Financing
Comparable Companies
XMAD:FAE XMAD:RJF ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124 BOM:532321 BOM:543904 TSE:4523 NSE:TORNTPHARM
Traded in Other Exchanges
0O9B:UK ALM:Spain E2Z:Germany
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Website
http://www.almirall.es
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.